Physician

Satish Chada, M.D.

According to 2025 Medicare claims, Satish Chada, M.D. (NPI: 1215915558) practices critical care (intensivists) in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is PULMONARY SERVICES OF NORTH TEXAS PLLC (NPI: 1275934747; TIN: 471791717) and primary practice location at 76301-5602. Chada is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Chada's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 805 traditional Medicare patients, billed 13,481 HCPCS/CPT codes, and received $465,175 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,762 prescription claims across 268 beneficiaries totaling $1,448,922 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 3,015 claims. Open Payments data shows 149 records totaling $2,887. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $301,318 to $465,175. Similarly, Part D prescription costs have moved sharply higher in recent years, from $418,834 to $1,448,922. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,063	3,941	$301,318
2016	1,102	6,717	$341,812
2017	1,162	6,525	$328,696
2018	1,113	9,705	$397,481
2019	1,061	13,213	$478,345
2020	1,013	11,620	$484,699
2021	955	10,990	$490,889
2022	932	8,669	$409,847
2023	839	9,540	$397,047
2024	805	13,481	$465,175

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	179	1,296	$418,834
2016	185	1,178	$411,594
2017	200	1,370	$442,487
2018	218	1,358	$483,821
2019	206	1,343	$426,057
2020	195	1,343	$560,219
2021	195	1,357	$777,461
2022	231	1,390	$951,058
2023	249	1,668	$1,449,918
2024	268	1,762	$1,448,922

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	631	2,297	$264,411
2016	746	3,368	$369,395
2017	793	3,445	$331,498
2018	718	3,298	$328,296
2019	771	3,150	$433,220
2020	716	3,143	$487,001
2021	835	3,306	$478,566
2022	737	2,982	$359,830
2023	817	3,324	$403,794
2024	690	3,015	$402,338

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	201	388	$158
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	331	543	$90
94729	Test to examine how well the lungs exchange gases	188	188	$35
94726	Test to determine lung volumes using sensors	187	187	$35
94618	Test for exercise-induced lung stress	146	146	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	44	1,320	$578,274
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	455	17,940	$382,126
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	160	5,300	$106,709
Dupixent Pen	Dupilumab	11	476	$67,403
Spiriva Respimat	Tiotropium Bromide	71	2,855	$47,528

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	25	155	$157,310
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	18	155	$119,495
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	76	600	$45,137
E1392	Portable oxygen concentrator, rental	Y	33	256	$8,649
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	17	106	$7,838

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	149	$2,887	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Satish Chada, M.D.?

Tedicare shows public-source Medicare data for Satish Chada, M.D. (NPI 1215915558), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Satish Chada, M.D. have ACO affiliation data?

Satish Chada, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Satish Chada, M.D.?

Satish Chada, M.D. is linked to PULMONARY SERVICES OF NORTH TEXAS PLLC (billing NPI 1275934747) in the available physician profile data.

Does Satish Chada, M.D. have Open Payments data?

Satish Chada, M.D. has 149 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.